prevention of adverse drug reactions

Zoeticx, Inc., the developer of medical software that bridges the gap between medical data and quality patient care, today announced a crowd funding campaign for TruRecord, the first subscriber-based, medical prescribing software to leverage advanced DNA testing technology for optimal drug analysis and prevention of adverse drug reactions. The company is raising funds for a fall launch of TruRecord on medical crowd funding site Medstartr...TruRecord improves patient outcomes by reducing the 80,000 annual deaths due to drug adverse reactions, resulting in 289 billion spent annually on malpractice payouts.

Read More »